Infervision Closes $47 Million B+ Round for AI-aided CT Scan Analysis

Infervision of Beijing raised $47 million in a B+ round to support its AI-aided CT cancer scanning software. So far, the company has developed two products, one for early detection of lung cancer and the other for detecting cardiothoracic lesions. Infervision says its products shorten the time a radiologist needs to read a scan while also increasing the accuracy of the readings. Participants in the funding were existing investors Sequoia Capital China, Qiming Venture Partners and Genesis Capital, along with new investors Xianghe Capital and Advantech Capital. More details.... Share this with colleagues: // //